![CRA-logo CRA-logo](https://cigarrights.org/wp-content/uploads/bb-plugin/cache/CRA-logo-landscape-5fa965420abfdd988999af4d2af0b85a-.jpg)
Generational Tobacco Bans: A Growing Focus in the US & Worldwide
As the concept of generational tobacco bans gain momentum across the country and the globe, the debate continues to intensify over their impact on public health, personal freedoms, and the…
![US_Supreme_Court US_Supreme_Court](https://cigarrights.org/wp-content/uploads/bb-plugin/cache/US_Supreme_Court-scaled-landscape-a5abd78d78ed353d877cdb4cd03b6803-.jpg)
Supreme Court Rulings Signal New Era for Federal Regulatory Power: Implications for the Premium Cigar Industry
By: Mike Copperman, Executive Director of Cigar Rights of America In the final days of its blockbuster 2024 term, the Supreme Court released two significant decisions on Executive Agencies’ regulatory…
![](https://cigarrights.org/wp-content/uploads/bb-plugin/cache/US_Supreme_Court-1024x768-landscape-b85d474ddedc294fcfcb437bb480c864-.jpg)
Supreme Court Overturns Chevron Deference
By Cody Carden Earlier today, the Supreme Court published their decision in Loper Bright v. Raimondo, a case which significantly curtails the power of federal agencies such as the Food and Drug…
![CRA-logo CRA-logo](https://cigarrights.org/wp-content/uploads/bb-plugin/cache/CRA-logo-landscape-5fa965420abfdd988999af4d2af0b85a-.jpg)
The Power of One: Why Your Voice Matters in Cigar Rights Advocacy
In the realm of advocacy, every individual voice can be a powerful catalyst for change. For those of us who cherish the art of enjoying cigars, the need to speak…
Cigar News
Washington, DC: In this article by Bloomberg's Suzanne Monyak, a significant but underappreciated side-effect of the pending SCOTUS decision in Loper Bright Enterprises v. Raimondo is raised: Agencies' being deluged with lawsuits addressing their regulations. As discussed in this prior article by CRA's Cody Carden Loper Bright, a case about Chevron deference could drastically alter the courts' capacity to second-guess agency rulemaking. This will likely drive massive numbers of plaintiffs into court, challenging a rule-making process that, to this point, has been highly deferential to Agencies over the past 40 years. This is significant for CRA not only because we would be able to force the FDA to be more diligent in their rule-making, but also because the increased work-load on net would make the need for them to prioritize the most pressing issues all the more, and, as recommended by the Reagan-Udall Foundation, deprioritize premium cigar regulation, an issue which has not only consumed a disproportionate amount of their time, money, and which, even with the high level of deference granted to them under Chevron, has led to losses in federal court.